Generalisation from phase III clinical trials: survival, quality of life, and health economics.

Lancet

PubMedID: 9329528

Fayers PM, Hand DJ. Generalisation from phase III clinical trials: survival, quality of life, and health economics. Lancet. 1997;350(9083):1025-7.
An abstract is not available